These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10139579)

  • 1. Caremark probe widens; infusion unit sale near.
    Burns J
    Mod Healthc; 1995 Jan; 25(4):2-3. PubMed ID: 10139579
    [No Abstract]   [Full Text] [Related]  

  • 2. Caremark may sell home infusion arm.
    Burns J
    Mod Healthc; 1994 Oct; 24(44):6. PubMed ID: 10138155
    [No Abstract]   [Full Text] [Related]  

  • 3. Sale to Coram infuses Caremark.
    Burns J
    Mod Healthc; 1995 Feb; 25(6):2-3. PubMed ID: 10139825
    [No Abstract]   [Full Text] [Related]  

  • 4. Caremark records $52 million charge.
    Shriver K
    Mod Healthc; 1996 Jan; 26(5):12-3. PubMed ID: 10154146
    [No Abstract]   [Full Text] [Related]  

  • 5. Caremark to plead guilty in fraud case.
    Shriver K
    Mod Healthc; 1995 Jun; 25(25):6. PubMed ID: 10143103
    [No Abstract]   [Full Text] [Related]  

  • 6. New action in Caremark cases.
    Shriver K
    Mod Healthc; 1996 Jan; 26(4):8-9. PubMed ID: 10154144
    [No Abstract]   [Full Text] [Related]  

  • 7. Another Caremark exec faces charges.
    Shriver K
    Mod Healthc; 1995 Jul; 25(29):14. PubMed ID: 10144036
    [No Abstract]   [Full Text] [Related]  

  • 8. Caremark sells another unit; more in works?
    Burns J
    Mod Healthc; 1995 Feb; 25(9):50. PubMed ID: 10140283
    [No Abstract]   [Full Text] [Related]  

  • 9. Federal probe ends; T2 to pay $500,000.
    Burns J
    Mod Healthc; 1994 Oct; 24(40):58. PubMed ID: 10137223
    [No Abstract]   [Full Text] [Related]  

  • 10. Canada's emerging home infusion market.
    Chielli J
    Caring; 1997 Jul; 16(7):36-8. PubMed ID: 10169881
    [No Abstract]   [Full Text] [Related]  

  • 11. The Medicare reimbursement puzzle for home drug infusion therapy.
    Pace KB
    Caring; 1995 May; 14(5):10-2. PubMed ID: 10142346
    [No Abstract]   [Full Text] [Related]  

  • 12. Future trends affecting the home infusion therapy industry.
    Geniusz GM
    Caring; 1995 May; 14(5):58-62. PubMed ID: 10142356
    [No Abstract]   [Full Text] [Related]  

  • 13. IRS taking a closer look. As bond probe widens, debt issued to form MedStar Health is now subject of legal analysis.
    Jaklevic MC
    Mod Healthc; 2000 Aug; 30(34):6. PubMed ID: 11185169
    [No Abstract]   [Full Text] [Related]  

  • 14. A cost containment program targeting home infusion drug therapy.
    Richards JW; Taylor WJ
    Physician Exec; 1994 Nov; 20(11):38-41. PubMed ID: 10140895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baxter to acquire Caremark in $528 million stock swap.
    Lutz S
    Mod Healthc; 1987 May; 17(11):10. PubMed ID: 10282373
    [No Abstract]   [Full Text] [Related]  

  • 16. Big second-quarter loss hammers Coram stock.
    Shriver K
    Mod Healthc; 1995 Aug; 25(34):3, 14. PubMed ID: 10144517
    [No Abstract]   [Full Text] [Related]  

  • 17. Grace receives another offer for National Medical.
    Moore JD
    Mod Healthc; 1995 Jun; 25(24):4. PubMed ID: 10142746
    [No Abstract]   [Full Text] [Related]  

  • 18. Caremark set to buy group, stalks another.
    Wagner M
    Mod Healthc; 1992 Sep; 22(36):3. PubMed ID: 10120352
    [No Abstract]   [Full Text] [Related]  

  • 19. Gaps in home infusion therapy coverage could spark policy debate.
    Craven & Ober, Policy Strategists, LLC
    J Infus Nurs; 2007; 30(4):201-2. PubMed ID: 17667071
    [No Abstract]   [Full Text] [Related]  

  • 20. Coram posts smallest loss in two years.
    Saphir A
    Mod Healthc; 1999 Mar; 29(10):12. PubMed ID: 10345688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.